Sandoz Group (OTCMKTS:SDZNY) Shares Gap Down – What’s Next?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) gapped down before the market opened on Wednesday . The stock had previously closed at $83.75, but opened at $79.84. Sandoz Group shares last traded at $79.91, with a volume of 6,076 shares changing hands.

Wall Street Analyst Weigh In

Separately, Barclays raised Sandoz Group to a “strong-buy” rating in a report on Monday, October 13th. One investment analyst has rated the stock with a Strong Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Sandoz Group has a consensus rating of “Moderate Buy”.

Sandoz Group Stock Performance

The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.82 and a current ratio of 1.29. The stock has a 50-day moving average price of $73.62 and a two-hundred day moving average price of $65.53.

Sandoz Group Company Profile

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.